Detalhe da pesquisa
1.
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression.
Haematologica
; 106(7): 1943-1956, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354870
2.
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.
Blood
; 126(12): 1443-51, 2015 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26185130
3.
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.
Am J Hematol
; 91(10): 995-1001, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351715
4.
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
J Pathol
; 229(1): 87-98, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22847671
5.
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes.
Biomark Res
; 12(1): 43, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654298
6.
Unraveling the Role of Peroxisome Proliferator-Activated Receptor ß/Δ (PPAR ß/Δ) in Angiogenesis Associated with Multiple Myeloma.
Cells
; 12(7)2023 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37048084
7.
Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network.
Front Oncol
; 11: 739171, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34513714
8.
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma.
J Clin Med
; 9(2)2020 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32085480
9.
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients.
Oncoimmunology
; 8(1): e1486949, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30546939
10.
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma.
Oncotarget
; 9(29): 20563-20577, 2018 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755672
11.
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target.
Clin Cancer Res
; 20(22): 5796-807, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25212607
12.
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.
Clin Cancer Res
; 20(4): 847-58, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297864
13.
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma.
Clin Cancer Res
; 17(7): 1935-46, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21307145
14.
Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma.
Eur J Cancer
; 46(2): 420-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19914061